These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9836374)

  • 1. Joint inflammation and cartilage destruction may occur uncoupled.
    van den Berg WB
    Springer Semin Immunopathol; 1998; 20(1-2):149-64. PubMed ID: 9836374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.
    van den Berg WB; Bresnihan B
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):577-97. PubMed ID: 10652641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.
    Joosten LA; Smeets RL; Koenders MI; van den Bersselaar LA; Helsen MM; Oppers-Walgreen B; Lubberts E; Iwakura Y; van de Loo FA; van den Berg WB
    Am J Pathol; 2004 Sep; 165(3):959-67. PubMed ID: 15331419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis.
    van de Loo FA; Joosten LA; van Lent PL; Arntz OJ; van den Berg WB
    Arthritis Rheum; 1995 Feb; 38(2):164-72. PubMed ID: 7848306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.
    Kuiper S; Joosten LA; Bendele AM; Edwards CK; Arntz OJ; Helsen MM; Van de Loo FA; Van den Berg WB
    Cytokine; 1998 Sep; 10(9):690-702. PubMed ID: 9770330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF alpha and IL-1 beta are separate targets in chronic arthritis.
    van den Berg WB; Joosten LA; van de Loo FA
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S105-14. PubMed ID: 10589368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling of inflammatory and destructive mechanisms in arthritis.
    van den Berg WB
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):7-16. PubMed ID: 11357166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].
    Seemayer CA; Distler O; Kuchen S; Müller-Ladner U; Michel BA; Neidhart M; Gay RE; Gay S
    Z Rheumatol; 2001 Oct; 60(5):309-18. PubMed ID: 11759230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.
    Lubberts E; Joosten LA; Helsen MM; van den Berg WB
    Cytokine; 1998 May; 10(5):361-9. PubMed ID: 9619374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.
    van den Berg WB; Joosten LA; Kollias G; van De Loo FA
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I40-8. PubMed ID: 10577972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
    van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
    Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
    Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].
    Leonaviciene L; Bradūnaite R; Astrauskas V
    Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.